Advertisement
Research Article Free access | 10.1172/JCI117293
Section of Clinical Nutrition and Lipid Metabolism, Oregon Health Sciences University, Portland 97201.
Find articles by Anderson, G. in: JCI | PubMed | Google Scholar
Section of Clinical Nutrition and Lipid Metabolism, Oregon Health Sciences University, Portland 97201.
Find articles by Tso, P. in: JCI | PubMed | Google Scholar
Section of Clinical Nutrition and Lipid Metabolism, Oregon Health Sciences University, Portland 97201.
Find articles by Connor, W. in: JCI | PubMed | Google Scholar
Published June 1, 1994 - More info
The developing brain obtains polyunsaturated fatty acids from the circulation, but the mechanism and route of delivery of these fatty acids are undetermined. 14C-labeled chylomicrons were prepared by duodenal infusion of [1-14C]16:0, [1-14C]18:2(n-6), [1-14C]18:3(n-3), or [1-14C]22:6(n-3) into adult donor rats, and were individually injected into hepatectomized 2-wk-old suckling rats. After minor correction for trapped blood in the brain, the incorporation of chylomicron fatty acids after 30 min was nearly half that of a co-injected free fatty acid reference. [1-14C]22:6(n-3)-labeled chylomicrons showed an average 65% greater incorporation than chylomicrons prepared from the other fatty acids. This apparent selectivity may have been partly due to lower oxidation of 22:6(n-3) in the brain compared to the other fatty acids tested, based on recovered water-soluble oxidation products. The bulk of the radioactivity in the brain was found in phospholipid and triacylglycerol, except that animals injected with [1-14C]22:6(n-3) chylomicrons showed considerable incorporation also into the fatty acid fraction instead of triacylglycerol. These data show that chylomicrons may be an important source of fatty acids for the developing rat brain.
Click on an image below to see the page. View PDF of the complete article